Comparing the abundance of FGFR2 in livers from healthy subjects versus non-tumorous (histologically normal) tissue taken from cancer patients and tumorous samples, we found significantly lower values in non-tumorous tissue but no statistically significant change in tumorous samples. The gene discussed is FGFR2; the disease is cancer.